“…Based on their ability to unwind both DNA strands at once, topoisomerases are categorized into two groups, topoisomerase I and topoisomerase II. 20 Topoisomerases I and II (Top 1 and Top 2 as they are more often known) are largely considered to be significant molecular targets for the development of anticancer medicines. 21 Irinotecan, topotecan, and camptothecin are well-known examples of topoisomerase I (Topo I) inhibitors.…”
We reported a novel 2-coumarin-substituted-quinoxaline analogue (3b) with potential antiproliferative activity against MCF-7 breast cancer cells by inducing cell cycle arrest and targeting topoisomerase II, and EGFR activity.
“…Based on their ability to unwind both DNA strands at once, topoisomerases are categorized into two groups, topoisomerase I and topoisomerase II. 20 Topoisomerases I and II (Top 1 and Top 2 as they are more often known) are largely considered to be significant molecular targets for the development of anticancer medicines. 21 Irinotecan, topotecan, and camptothecin are well-known examples of topoisomerase I (Topo I) inhibitors.…”
We reported a novel 2-coumarin-substituted-quinoxaline analogue (3b) with potential antiproliferative activity against MCF-7 breast cancer cells by inducing cell cycle arrest and targeting topoisomerase II, and EGFR activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.